AstraZeneca PLC Ordinary Shares (AZN)
SG&A Expense Growth
14.52%
Quarterly · Period ending:
AZN SG&A Expense Growth
Latest reported14.52%period ending
Latest reported14.52%period ending
AZN Quarterly SG&A Growth (QoQ) (0.00% → 14.52%)
Latest values, visible window
High-resolution chart · PNG
AZN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.9705% | |
| 0% | |
| -100% | |
| -1.9082% | |
| 3.4083% | |
| 0% | |
| -100% | |
| -14.1109% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |